ATCase activity is regulated by several mechanisms, including allosteric regulation, feedback inhibition, and gene expression control. In normal cells, ATCase is inhibited by the end-products of the pyrimidine pathway, such as CTP, ensuring a balance in nucleotide levels. However, in cancer cells, these regulatory mechanisms may be disrupted, leading to increased enzyme activity and uncontrolled nucleotide synthesis.
